BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 608-614
Vol. 155, No. 2, 1988 September 15, 1988
AMYLOID FIBRILS FORMED FROM A SEGMENT OF THE P A N C R E A T I C ISLET A M Y L O I D P R O T E I N George
G.
Glenner, M.D. E. D a v i d Eanes, and C l a y t o n A. Wiley, M.D.
University
of C a l i f o r n i a , San D i e g o La Jolla, CA 92093
Ph.D.*
(M-012)
* N a t i o n a l I n s t i t u t e s of D e n t a l R e s e a r c h , N a t i o n a l I n s t i t u t e s of Health, B e t h e s d a , MD 20892
Received July 18, 1988
SUMMARY: A s y n t h e t i c p e p t i d e f o r m e d from r e s i d u e s 20-29 of the p a n c r e a t i c islet a m y l o i d p r o t e i n has the c o n f i r m a t i o n of a t w i s t e d g-pleated sheet protein s u g g e s t i n g it is a p o t e n t i a l c o n t r i b u t o r toward amyloid fibril formation in the islets of L a n g e r h a n s in Type 2 d i a b e t e s m e l l i t u s . ©1988AcademicPress,lnc.
Amyloid arranged
in
a
conformation fibrils is
fibrils
chain
usually
of
prealbumin
varies
variants
inflammatory
are
disease
(6,7)
in
the
amyloid
sheet
or
twisted
nature with
of the p r o t e i n the
is
fibrils
protein
dialysis
seen
in
where
the
fibril
0006-291X/88 $1.50 Copyright © 1988 by Academic Press, Inc. All rights of reproduction in "any form reserved.
the
in
fibrils
protein the
608
light
which
myeloma
SAA
of
the
deposits
in
(3),
in of
plaques
in
of
the
~2
deposits
thyroid
Recently
(2),
protein
cerebral composed
it
polypeptide
Localized as
sheet amyloid
polyneuropathy
are
(8).
the
with
multiple
(5).
carcinoma
comprising
of
sites
g-pleated
condition
amyloidosis;
such
(or p o l y p e p t i d e s )
composing
amyloidotic
amyloidosis
medullary the
clinical
deposits
in f a m i l i a l
(reactive)
Alzheimer's
precalcitonin
proteins
systemic
in
fibers
and
of
immunoglobulin
microglobulin
amyloid
The
e.g.
an
composed
g-pleated
(i).
associated
are
g
protein where
a
protein
of
insulinomas
and
in
Vol. 155, No. 2, 1 1 9 8 8
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Table
I
CGRP
A
C
D
T
A
T
C
V
T
I0 H R
L
A
G
L
L
S
R
S
lAP
K
C
N
T
A
T
C
A
T
Q
R
L
A
N
F
L
V
H
S
20
CGRP
G
G
V
V
K
N
N
F
V
P
30 T N
V
G
S
K
A
F
lAP
S
N
N
F
G
A
I
L
S
S
T
V
G
S
N
T
Y
Amino acid (underlined)
the
of
islets
mellitus
reveals
it
It
to
is not
has This
have
pancreas
isolated
analysis 46%
of
(i0).
evident
that
the
to
specific by
the
for
method
cysteine
solvents
of
Attempts
were
from
to
20
A
to
29
in
study
was
with
protein
a C-
carrier the
of
of
obtain
(IP20)
IP20
further
to
(ii)
a
lAP,
calcitonin
order
Merrifield
solubilize
unsuccessful.
the
In
sequence
protein;
residues
coupling to
with
2 diabetes
acid
decapeptide
and
for
type
amyloid
CGRP.
of M a r g l i n
of
amino
i)
this
incorporated (12).
islet
sequence
lAP
59%
its
(Table
that
Residues
in
and
the
homology
CGRP
immunization
coupling
the
been
homologous
synthesized terminal
of
peptide,
is
antibodies
for
Langerhans
(9).
gene-related
IAP
sequence of lAP and CGRP. from 20-29 show no homology.
patients
determined
N
usual
IP20
was
performed
by
undertaken.
Material Congo
red
previously
staining described
microscope.
beta
(i).
of
lAP
strand
examination The
methods
studies
of
and
(6)
microscopy
utilized
staining (6).
CGRP turn
this
material were
those
beta
of
recorded
609
on
Orthoplan
the
hydropathy,
as
film
polarizing
employed
evaluate
X-ray
performed
was
were
to
(13).
was
an
methods
Indices
were
and
photographs
Methods
polarization
Negative
ultrastructural structure
and
and
secondary
alpha
helix,
crystallographic
previously using
for
either
described a
57.3mm
Vol. 155, No. 2, 1988
(4589,
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
4589R2)
powder
camera
or and
a
l14.6mm
CuK~
(4589R3)
diameter
Debye-Scherrer
radiation.
Result~ The smeared this
synthesized
on
a
material
amyloid
sharp
4.75
figure
~
broad much
X-ray
diffraction
fairly
a
slide
revealed
fibrils.
dominant
of
glass
line
at
than a
the
features
characteristic
Figure
with
I.
in
A.
of
sheet the A
line of
microscopic an
average
the
is
a k-pattern structure
8.6
color
(14).
features Principal A.
These
twisted
k-pleated
of
amyloid
fibrils
examination of
of
indicative
of
is
is
more
Besides in
the
among two
that a
less
the
strong, than
the
suggestive some
very
pattern these
sheet
are
structure,
(I).
~ with
filamentous narrowings
X-ray diffraction pattern demonstrating major bands at 4.64 ~ ("back-bone" spacing) (arrow) and 8.3 A ("sidechain" spacing) (arrowhead) indicative of a twisted gpleated sheet structure.
610
are
latter
d-spacings
revealed 50-80
i)
IP20
somewhat and
water,
staining
(Fig.
for
a
width
red
revealed
value
other
distilled
Congo
pattern
line.
at
in
polarization
This
characteristic
Electron
dried.
crystallography
4.64
weaker
dispersed
air
green
scatter,
is
structures
a
4.64
k-pleated
background
defining
and
feature
features
the
was
characteristic
twisted
weaker
IP20
Vol. 155, No. 2, 1988
Figure 2.
consisting revealed the beta
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Electron mierograph Bar = 0.i #m.
of
twists
distinct
various
(Fig,
2).
differences
indices
examined
of
70-80
A w i d e fibrils
Only between
e. g.
the IAP
alpha
of
hydropathic and
CGRP
helix,
beta
(Fig.
IP20.
index 3)
strand
of and
turn. Discussion The
results
comprising
of
residues
the
20-29
examination of
the
lAP
of
the
molecule
synthetic
peptide
reveal
to
it
have
2.2
1.3
mx 0,4 -.0.5
~. -1.4 .,~
-2.3 -3.2
:-CGRP
~'-.,-~ IA P
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Amino A c i d s Figure 3.
Hydropathy Index shows dramatic hydrophobicity b e t w e e n C G R P a n d I A P 29. 611
distinction from residues
in
20-
Vol. 155, No. 2, 1988 the
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
tinctorial,
characteristics twisted this
of
of
sheet
lAP
of t h e s e
to
contributor
to
lAP
the
other
protein.
toto
of
into
by
intrinsic fibrils
can be free
energy Many
N-pleated known
influenced
adherence
(19).
therefore,
Chou
and
activity
the
of
of
20-29
sheet
been
a
N2
of
to
the
vast
that
segment
glucagon sheet
the
destined
of
the
have
into
by
the
Nover
a
form
high
amyloid
intrinsic
and p o l y - l - l y s i n e
fibrils
in
amyloid
have
an
N
amyloid
created
(18)
to
of
intact
intrinsic
majority
(20)
of
form
created
devoid
segments
being
microglobulin
(15)
in
of
significant
proteins
lAP are
fibrils
18-28
found
the
conformation
amyloid
residues
On
of
synthetic
capable
although
as
to
to
the have
antigen,
the
N
(21)
introduction
region
that,
these
when
reside
612
and
the
of
cell
ability
the
on
the
light
binding
to r e g u l a t o r
(inherent to
of
N-structure
selective
applied
suggested
"in its
Based
immunoglobulin that
tight
molecules
subsequently
of
seemed
case
significance
proposed.
~-structure
of
glucagon may
been
it
in this
suggested
(22)
functional
variable
and
binding
Fasman
that
(6) has
have
(20),
the
proteins,
influenced
residues
reveals
CGRP.
N-configuration
Of those
in
of
chains
hormonal
of
of
system.
polypeptide
We,
the
and
conformation
interaction
shown
proteins
(17)
suggestions sheet
that
the N - p l e a t e d
have
to N - p l e a t e d
to the
that
decapeptide
insulin
converted
from
index
mellitus.
However,
both
hydropathic
2 diabetes
proteolysis
structure,
conformation
in Type
N-structure.
(19).
the
as
fibrils
N-structure
i.e.
ultrastructural
deposition
disease
Prealbumin
and
its
Usually
amyloid
intrinsic
fibrils
to
synthetic
(13,16).
it
conclude
can h a v e
Alzheimer's
structure. 50%
and
proteins
The
fibrils
we
investigations
amyloid
protein
distinguish
of L a n g e r h a n s
Recent
(15) The
in c o n f e r r i n g
molecule
islets
fibrils
fibrils.
findings
a major the
crystallographic
amyloid
N-pleated
region
basis
x-ray
or
induced)
receptors
that
the
to a s s u m e
or
(20).
biologic a folded
Vol. 155, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
conformation
upon
the
of
adoption
Recently
the
interaction a
having
protein,
suggested of
soluble, noted
associated a wide
a
small,
such
that
of
as
variety
(23)
retinol
these
the
it
is
possible
just
the
the
amino
understanding
and
the
of
structure
this
basic
molecules
of
are
labile
has
a
influenced
either both. seem the
It
to
have
potential
was an for
interaction,
capacity.
Since
structure
methodologies
architecture
the
sparingly
three-dimensional
newer
protein
binding
diverse
retinol-binding
protein-protein
in a r e c e p t o r
i.e.
binding.
three
or
all
~-strueture
sequence,
receptor
structure
proteins
predict
receptors"
e.g.
that
A),
including
native
upon
K-structure,
the
to
acid
specific
structure
mammalian
of f u n c t i o n s carrier
its
(Vitamin
Thus,
a molecular
from
that
conjugated
as
yet
of
significant
receptor.
not
compact
commonality
proteins
binding
more
with
are
more
making
feasible
(24).
Acknowledgment We w i s h of
Patrick
Olshefski grant
Burrola
for
#DK34609
and K i d n e y
to a c k n o w l e d g e
the from
Disease,
in
peptide
the
excellent
the u l t r a s t r u c t u r a l synthesis.
the N a t i o n a l
This
Institute
technical studies
study
was
assistance and
Dennis
supported
of D i a b e t e s ,
by
Digestive
NIH. References
1
.
2. 3. 4.
5 .
6. 7.
Eanes, E.D. and Glenner, G.G. (1968) J. Histoehem. C y t o e h e m . 16. 673-677. Glenner, G.G., Terry, W., Harada, M., Isersky, C., and Page, D. (1971) S c i e n c e 172. 1 1 5 0 - 1 1 5 1 . Dwulet, F.E. and Benson, M.D. (1984) Prec. Natl. Aead. Sci. U S A 81. 694-698. G o r e v i e , P.D., Munoz, P.C., Casey, T.T., D i R a i m o n d o , C.R., Stone, W.J., Prelli, F.C., R o d r i g u e s , M.M., Poulik, M.D., and Frangione, B. (1986) Prec. Natl. Acad. Sci. U S A 83. 7908-7912. Rosenthal, C.J., Franklin, E.C., Frangione, B., and G r e e n s p a n , J. (1976) J. Immunol. 116. 1 4 1 5 - 1 4 1 8 . G l e n n e r , G.G. and W o n g C.W. (1984) Biochem. B i o p h y s . Res. Commun. 120. 885-890. G l e n n e r , G.G. and W o n g C.W. (1984) Biochem. B i o p h y s . Res. Commun. 122. 1 1 3 1 - 1 1 3 5 .
613
Vol. 155, No. 2, 1988
8 .
9.
I0. ii. 12. 13. 14. 15. 16.
17 18 19 20 21 22 23 24.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Sletten, K., W e s t e r m a r k , P. , and N a t v i g , J.B. (1976) J. Exp. Med. 143. 993-998. W e s t e r m a r k , P., W e n s t e d t , C., W i l a n d e r , E. , H a y d e n , D.W., O ' B r i e n , T.D., and J o h n s o n , K.H. (1987) Proc. Natl. Acad. Sci. U S A 84. 3 8 8 1 - 3 8 8 5 . A m a r a , S.G., Jonas, V., R o s e n f e l d , M.G. , Ong, E.S., and Evans, R.M. (1982) N a t u r e 298. 240-244. M a r g l i n , A. and M e r r i f i e l d , R.B. (1970) Ann. Rev. Biochem. 39. 84-866. W a l t e r , G. and D o o l i t t e , R.R. (1983) G e n e t i c E n g i n e e r i n g : P r i n c i p l e s and M e t h o d s . P l e n u m N e w York, 61-91. G o r e v i c , P.D., C a s t a n o , E.M. , Sarma, R., and F r a n g i o n e , B. (1987) B i o c h e m . B i o p h y s . Res. Commun. 147. 8 5 4 - 8 6 2 . C h o t h i a , C. (1973) J. Mol. Biol. 75. 2 9 5 - 3 0 2 . Glenner, G.G. (1980) N. Eng. J. Med. 302. 1283-1292, 1333-1343. Kirschner, D.A. , Inouye, H. , Duffy, L.K. , S i n c l a i r , A. , Lind, M. , and Selkoe, D.J. (1987) Proc. Natl. Acad. Sci. U S A 84. 6 9 5 3 - 6 9 5 7 . Blake, C.C.F. , Geisow, M.J. , Swan, I.D.A. , Rerat, G. , and Rerat, B. (1974) J. Molec. Biol. 88. 1-12. B e c k ~ r , J.W. and Reeke, G.N., Jr. (1985) Proc. Natl. Acad. Sci. U S A 82. 4 2 2 5 - 4 2 2 9 . E d m u n d s o n , A.B. , Ely, K.R., Abola, E.E., S c h i f f e r , M., and P a n a g i o t o p o u l o s , N. (1975) B i o c h e m i s t r y 14. 3 9 5 3 - 3 9 6 1 . G l e n n e r , G.G. , Eanes, E.D. , Bladen, H.A. , Linke, R.P. , and T e r m i n e , J.D. (1974) J. H i s t o c h e m . C y t o c h e m . 22. 1 1 4 1 - 1 1 5 8 . G l e n n e r , G G., Eanes, E.D., and Page, D.L. (1972) J. H i s t o c h e m . ~Cyhochem. 20. 821-826. C h o u , P.Y. and Fasman, G.D. (1975) B i o c h e m i s t r y 14. 25362541. Sawyer, L. (1987) N a t u r e 327. 659. C r e i g h t o n , T.E. (1988) S c i e n c e 240. 267, 344.
614